Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,209
New position
Shares Held
180
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HARBOUR INVESTMENTS, INC. holds $3,583,420 across 30 Diagnostics & Research names. BLLN ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
4,124 | $2,027,069 | |
| 2 | LH |
Labcorp Holdings Inc.
|
1,534 | $409,286 | |
| 3 | DHR |
Danaher Corp /De/
|
1,564 | $296,534 | |
| 4 | WAT |
Waters Corp /De/
|
646 | $192,378 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
819 | $139,672 | |
| 6 | DGX |
Quest Diagnostics Inc
|
696 | $136,402 | |
| 7 | CSTL |
Castle Biosciences Inc
|
3,248 | $79,738 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
135 | $75,855 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,209 | 180 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||